BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14672946)

  • 1. The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1.
    Velasco-Loyden G; Arribas J; López-Casillas F
    J Biol Chem; 2004 Feb; 279(9):7721-33. PubMed ID: 14672946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Betaglycan has two independent domains required for high affinity TGF-beta binding: proteolytic cleavage separates the domains and inactivates the neutralizing activity of the soluble receptor.
    Mendoza V; Vilchis-Landeros MM; Mendoza-Hernández G; Huang T; Villarreal MM; Hinck AP; López-Casillas F; Montiel JL
    Biochemistry; 2009 Dec; 48(49):11755-65. PubMed ID: 19842711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betaglycan (TβRIII) is a Key Factor in TGF-β2 Signaling in Prepubertal Rat Sertoli Cells.
    Kudipudi PK; Galuska SP; Dietze R; Scheiner-Bobis G; Loveland KL; Konrad L
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration.
    Endo K; Takino T; Miyamori H; Kinsen H; Yoshizaki T; Furukawa M; Sato H
    J Biol Chem; 2003 Oct; 278(42):40764-70. PubMed ID: 12904296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The type III TGF-β receptor betaglycan transmembrane-cytoplasmic domain fragment is stable after ectodomain cleavage and is a substrate of the intramembrane protease γ-secretase.
    Blair CR; Stone JB; Wells RG
    Biochim Biophys Acta; 2011 Feb; 1813(2):332-9. PubMed ID: 21167215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MT1-MMP mediates MUC1 shedding independent of TACE/ADAM17.
    Thathiah A; Carson DD
    Biochem J; 2004 Aug; 382(Pt 1):363-73. PubMed ID: 15130087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans.
    Fukushima D; Bützow R; Hildebrand A; Ruoslahti E
    J Biol Chem; 1993 Oct; 268(30):22710-5. PubMed ID: 8226781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA.
    Matsumoto S; Katoh M; Saito S; Watanabe T; Masuho Y
    Biochim Biophys Acta; 1997 Nov; 1354(2):159-70. PubMed ID: 9396633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A.
    Esparza-Lopez J; Montiel JL; Vilchis-Landeros MM; Okadome T; Miyazono K; López-Casillas F
    J Biol Chem; 2001 May; 276(18):14588-96. PubMed ID: 11278442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme.
    Toth M; Hernandez-Barrantes S; Osenkowski P; Bernardo MM; Gervasi DC; Shimura Y; Meroueh O; Kotra LP; Gálvez BG; Arroyo AG; Mobashery S; Fridman R
    J Biol Chem; 2002 Jul; 277(29):26340-50. PubMed ID: 12004057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.
    Egawa N; Koshikawa N; Tomari T; Nabeshima K; Isobe T; Seiki M
    J Biol Chem; 2006 Dec; 281(49):37576-85. PubMed ID: 17050542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites.
    López-Casillas F; Payne HM; Andres JL; Massagué J
    J Cell Biol; 1994 Feb; 124(4):557-68. PubMed ID: 8106553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs).
    Lafleur MA; Handsley MM; Knäuper V; Murphy G; Edwards DR
    J Cell Sci; 2002 Sep; 115(Pt 17):3427-38. PubMed ID: 12154073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the juxtamembrane domains of the transforming growth factor-alpha precursor and the beta-amyloid precursor protein in regulated ectodomain shedding.
    Arribas J; López-Casillas F; Massagué J
    J Biol Chem; 1997 Jul; 272(27):17160-5. PubMed ID: 9202036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.
    Shek FW; Benyon RC; Walker FM; McCrudden PR; Pender SL; Williams EJ; Johnson PA; Johnson CD; Bateman AC; Fine DR; Iredale JP
    Am J Pathol; 2002 May; 160(5):1787-98. PubMed ID: 12000730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-(alpha) and membrane type matrix metalloprotease (MT1-MMP).
    Ureña JM; Merlos-Suárez A; Baselga J; Arribas J
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():773-84. PubMed ID: 10036228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase.
    Toth M; Osenkowski P; Hesek D; Brown S; Meroueh S; Sakr W; Mobashery S; Fridman R
    Biochem J; 2005 Apr; 387(Pt 2):497-506. PubMed ID: 15560752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration.
    Kajita M; Itoh Y; Chiba T; Mori H; Okada A; Kinoh H; Seiki M
    J Cell Biol; 2001 May; 153(5):893-904. PubMed ID: 11381077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes.
    Hotary KB; Yana I; Sabeh F; Li XY; Holmbeck K; Birkedal-Hansen H; Allen ED; Hiraoka N; Weiss SJ
    J Exp Med; 2002 Feb; 195(3):295-308. PubMed ID: 11828004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells.
    Annabi B; Pilorget A; Bousquet-Gagnon N; Gingras D; Béliveau R
    Biochem J; 2001 Oct; 359(Pt 2):325-33. PubMed ID: 11583578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.